72 related articles for article (PubMed ID: 29786574)
21. [Therapy with NO donors-antiatherogenic and antioxidant actions].
Grosser N; Schröder H
Herz; 2004 Feb; 29(1):116-22. PubMed ID: 14968347
[TBL] [Abstract][Full Text] [Related]
22. [Endothelial dysfunction in patients with angina pectoris of functional classes II and III].
Andreeva EO; Koriakina LB; Kuril'skaia TE; Pushkareva TA; Pivovarov IuI; Runovich AA; Chizhova EA; Tiuriumina EE
Klin Lab Diagn; 2008 Oct; (10):15-7. PubMed ID: 19069439
[TBL] [Abstract][Full Text] [Related]
23. Improvement of erectile function with Prelox: a randomized, double-blind, placebo-controlled, crossover trial.
Stanislavov R; Nikolova V; Rohdewald P
Int J Impot Res; 2008; 20(2):173-80. PubMed ID: 17703218
[TBL] [Abstract][Full Text] [Related]
24. [Anti-angina treatment in stable forms of angina pectoris with emphasis on nitrates].
Murín J
Vnitr Lek; 1999 Feb; 45(2):122-6. PubMed ID: 15641233
[TBL] [Abstract][Full Text] [Related]
25. Significance of the lipid profile and endothelium-dependent vasodilatation in the pathogenesis of microvascular angina.
Liu QM; Zhou SH; Qi SS; Zhao SP; Minghuib L
Cardiol J; 2008; 15(4):324-8. PubMed ID: 18698540
[TBL] [Abstract][Full Text] [Related]
26. Long-term treatment with the NO-donor molsidomine reduces circulating ICAM-1 levels in patients with stable angina.
Van Hove C; Carreer-Bruhwyler F; Géczy J; Herman AG
Atherosclerosis; 2005 Jun; 180(2):399-405. PubMed ID: 15910868
[TBL] [Abstract][Full Text] [Related]
27. Oral administration of L-arginine in patients with angina or following myocardial infarction may be protective by increasing plasma superoxide dismutase and total thiols with reduction in serum cholesterol and xanthine oxidase.
Tripathi P; Chandra M; Misra MK
Oxid Med Cell Longev; 2009; 2(4):231-7. PubMed ID: 20716909
[TBL] [Abstract][Full Text] [Related]
28. Effects of L-arginine on fibroblast growth factor 2-induced angiogenesis in a model of endothelial dysfunction.
Voisine P; Li J; Bianchi C; Khan TA; Ruel M; Xu SH; Feng J; Rosinberg A; Malik T; Nakai Y; Sellke FW
Circulation; 2005 Aug; 112(9 Suppl):I202-7. PubMed ID: 16159817
[TBL] [Abstract][Full Text] [Related]
29. Effects of xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with stable angina.
Li JJ; Hu SS; Fang CH; Hui RT; Miao LF; Yang YJ; Gao RL
Clin Chim Acta; 2005 Feb; 352(1-2):217-24. PubMed ID: 15653117
[TBL] [Abstract][Full Text] [Related]
30. L-arginine preferentially dilates stenotic segments of coronary arteries thereby increasing coronary flow.
Lauer T; Kleinbongard P; Rath J; Schulz R; Kelm M; Rassaf T
J Intern Med; 2008 Sep; 264(3):237-44. PubMed ID: 18341529
[TBL] [Abstract][Full Text] [Related]
31. [Effects of beta 1-adrenoblocker bisoprolol on endothelial dysfunction in patients with stable angina pectoris in combination with chronic obstructive pulmonary disease].
Grigor'eva NIu; Sharabrin EG; Kuznetsov AN; Mazalov KV; Kontorshchikova KN; Koroleva EF
Ter Arkh; 2009; 81(3):28-31. PubMed ID: 19459418
[TBL] [Abstract][Full Text] [Related]
32. [Prospects of endothelial dysfunction reversion in patients with congestive heart failure].
Vizir VA; Berezin AE
Klin Med (Mosk); 2000; 78(7):36-9. PubMed ID: 10979640
[TBL] [Abstract][Full Text] [Related]
33. Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function.
Wassmann S; Faul A; Hennen B; Scheller B; Böhm M; Nickenig G
Circ Res; 2003 Oct; 93(9):e98-103. PubMed ID: 14551237
[TBL] [Abstract][Full Text] [Related]
34. Relation of improvement in endothelium-dependent flow-mediated vasodilation after rosiglitazone to changes in asymmetric dimethylarginine, endothelin-1, and C-reactive protein in nondiabetic patients with the metabolic syndrome.
Wang TD; Chen WJ; Cheng WC; Lin JW; Chen MF; Lee YT
Am J Cardiol; 2006 Oct; 98(8):1057-62. PubMed ID: 17027571
[TBL] [Abstract][Full Text] [Related]
35. Effect of molsidomine and L-arginine in cyclosporine nephrotoxicity: role of nitric oxide.
Chander V; Chopra K
Toxicology; 2005 Feb; 207(3):463-74. PubMed ID: 15664273
[TBL] [Abstract][Full Text] [Related]
36. Carvedilol improves endothelium-dependent dilatation in patients with coronary artery disease.
Matsuda Y; Akita H; Terashima M; Shiga N; Kanazawa K; Yokoyama M
Am Heart J; 2000 Nov; 140(5):753-9. PubMed ID: 11054621
[TBL] [Abstract][Full Text] [Related]
37. Trapidil is as effective as isosorbide-dinitrate for treating stable angina pectoris: a multinational, multicenter, double-blind, randomized study.
Meinertz T; Lehmacher W;
Clin Res Cardiol; 2006 Apr; 95(4):217-23. PubMed ID: 16598591
[TBL] [Abstract][Full Text] [Related]
38. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men.
Adams MR; Forsyth CJ; Jessup W; Robinson J; Celermajer DS
J Am Coll Cardiol; 1995 Oct; 26(4):1054-61. PubMed ID: 7560599
[TBL] [Abstract][Full Text] [Related]
39. Prevention by NCX 4016, a nitric oxide-donating aspirin, but not by aspirin, of the acute endothelial dysfunction induced by exercise in patients with intermittent claudication.
Gresele P; Migliacci R; Procacci A; De Monte P; Bonizzoni E
Thromb Haemost; 2007 Mar; 97(3):444-50. PubMed ID: 17334512
[TBL] [Abstract][Full Text] [Related]
40. A pilot double-blind randomized placebo-controlled study of molsidomine 16 mg once-a-day in patients suffering from stable angina pectoris: correlation between efficacy and over time plasma concentrations.
Messin R; Fenyvesi T; Carreer-Bruhwyler F; Crommen J; Chiap P; Hubert P; Dubois C; Famaey JP; Géczy J
Eur J Clin Pharmacol; 2003 Jul; 59(3):227-32. PubMed ID: 12734607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
